GIULIANA CUCCINIELLO: Open Payments
NPI 1750992624 · EAST FALMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$751 in 31 payments from 14 companies in 2025. Trend: 2023 $93 · 2024 $315 · 2025 $751
Food & beverage: $751
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $181 |
| AstraZeneca Pharmaceuticals LP | 5 | $108 |
| ABBVIE INC. | 4 | $98 |
| Novartis Pharmaceuticals Corporation | 3 | $64 |
| Verona Pharma, Inc. | 2 | $44 |
| Phathom Pharmaceuticals, Inc. | 2 | $43 |
| Alnylam Pharmaceuticals Inc. | 2 | $41 |
| Novo Nordisk Inc | 2 | $36 |
| Xeris Pharmaceuticals, Inc. | 2 | $34 |
| Lilly USA, LLC | 1 | $23 |
Products named: AREXVY, BREZTRI, QULIPTA, LEQVIO, Ohtuvayre, VOQUEZNA, TRELEGY ELLIPTA, ONPATTRO.
Industry payments across MA — which companies pay providers there.
